TP53 and disorder of sexual differentiation: Indeed, these pathways were significantly impeded upon DSD treatment, evidenced by dramatically down-regulated levels of phosphorylated forms of the key factors in these pathways in a dose-dependent manner, such as p-Akt (T308), p-ERK (T202/Y204), and p-p53 (S392) (Figure 7).